Sensitive Skin Improvement Through Bioinformatics-Identified Cosmetic Ingredients That Regulate Transcriptome-Derived Biomarkers
Biomolecules · 09.06.2026 · 16 (6) · 843
DOI: 10.3390/biom16060843 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Biomolecules, online erschienen am 09.06.2026. Verfasst von Seo Hyeong Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cutis Biomedical Research Center Co., Ltd., Seoul 07327, Republic of Korea. Hauptthemen laut MEDLINE: Cosmetics, Skin, Transcriptome, Computational Biology. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of SMEs and Startups, Technology Development Program.
Abstract (Originalsprache)
Sensitive skin is characterized by hypersensitivity to normal stimuli, and objective diagnostic tools and treatments are still limited. Currently, cosmetics for sensitive skin are developed through the exclusion of known irritants rather than investigation into the underlying mechanisms of sensitivity. In this study, we developed an integrated pipeline combining transcriptome analysis via microneedle-based skin sampling (MISSM), bioinformatics, in vitro validation, and clinical assessment to identify sensitive skin-associated inflammatory biomarkers and cosmetic ingredients that regulate them. Candidate biomarkers and matched cosmetic ingredients were identified from transcriptomic data and validated in lactic acid-stimulated HaCaT and human dermal fibroblasts via qRT-PCR. A prototype emulsion was developed and evaluated in a 4-week open-label pilot clinical trial with longitudinal molecular monitoring via MISSM. After lactic acid stimulation, sensitive skin-associated biomarkers (MCOLN1, CYR61, PMAIP1, PTGS2, and HMGB2) were significantly upregulated in both cell types, and cosmetic ingredients that regulate these biomarkers were confirmed in vitro. The emulsion prototype demonstrated hypoallergenicity in a primary irritation test. In the pilot clinical trial, target biomarker expression was significantly reduced in MISSM-derived samples, with improvements in skin hydration, barrier function, redness, and sensory reactivity also observed. This integrated pipeline will enable the discovery of inflammatory biomarker-regulating cosmetic ingredients, with potential applicability to various inflammatory skin conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cutis Biomedical Research Center Co., Ltd., Seoul 07327, Republic of Korea.
- Precision Medicine Institute, Innowl Co., Ltd., Seoul 07801, Republic of Korea.
- AI Institute, Alopax-Algo Co., Ltd., Seoul 07801, Republic of Korea.
- Raphas Co., Ltd., Seoul 07793, Republic of Korea.
ORCID-Profile: Seo Hyeong Kim, Ji Hye Kim, Jin-Muk Lim, Do Hyeon Jeong, Kwang Hoon Lee
Förderung
- Ministry of SMEs and Startups
- Technology Development Program
Zitieren
APA
Kim, S. H., Kim, J. H., Shin, J. M., Choi, Y. M., Kim, D. S., Seo, S. M., Jang, E. Y., Lee, S. J., Lim, J. M., Han, M., Jeong, D. H., & Lee, K. H. (2026). Sensitive Skin Improvement Through Bioinformatics-Identified Cosmetic Ingredients That Regulate Transcriptome-Derived Biomarkers. Biomolecules, 16(6), 843. https://doi.org/10.3390/biom16060843
Vancouver
Kim SH, Kim JH, Shin JM, Choi YM, Kim DS, Seo SM, et al. Sensitive Skin Improvement Through Bioinformatics-Identified Cosmetic Ingredients That Regulate Transcriptome-Derived Biomarkers. Biomolecules. 2026;16(6):843. doi:10.3390/biom16060843
BibTeX
@article{Kim2026,
author = {Kim, Seo Hyeong and Kim, Ji Hye and Shin, Ji Min and Choi, Yoon Mi and Kim, Da Som and Seo, Su Min and Jang, Eun Young and Lee, Sung Jae and Lim, Jin-Muk and Han, Minsoo and Jeong, Do Hyeon and Lee, Kwang Hoon},
title = {Sensitive Skin Improvement Through Bioinformatics-Identified Cosmetic Ingredients That Regulate Transcriptome-Derived Biomarkers},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {843},
doi = {10.3390/biom16060843}
}
EUVIMED